← Open Payments lookup

JOSEPH ACQUAVIVA: Open Payments

NPI 1912054420 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,152 in 85 payments from 14 companies in 2025. Trend: 2023 $1,233 · 2024 $1,238 · 2025 $1,152

Food & beverage: $1,152
CompanyPaymentsAmount
ABBVIE INC.27$210
Neurocrine BioSciences, Inc.13$198
Teva Pharmaceuticals USA, Inc.11$181
Vanda Pharmaceuticals Inc.10$158
Alkermes, Inc.4$85
Axsome Therapeutics, Inc.5$76
Neos Therapeutics, LP4$65
Takeda Pharmaceuticals U.S.A., Inc.3$47
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$38
Supernus Pharmaceuticals, Inc.2$35

Products named: VRAYLAR, INGREZZA, AUSTEDO XR, FANAPT, ARISTADA, Auvelity, EXXUA, TRINTELLIX.

Industry payments across NJ — which companies pay providers there.